Labcorp Holdings (LH) After Investor Day And Higher Guidance Is It Fully Valued
Investor Day shifts attention to Labcorp Holdings guidance and strategy Labcorp Holdings (LH) put its 2026 Investor Day in the spotlight as management raised full-year revenue and adjusted EPS guidance, and tied that outlook to specialty diagnostics and biopharma lab services. Recent trading shows a mixed picture for Labcorp Holdings. The share price has climbed 13.81% over 90 days and 22.76% year to date, even thou…
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
